MAPK3 and diabetes mellitus: Here, we report that ERK1/2 is activated in the retinas of diabetic rats and 1,5-isoquinolinediol treatment inhibits ERK1/2 activation, thus suggesting that ERK activation may be a target of diabetes-associated PARP activation.